Skip to main content

Animations

MJFF Publications

4531 - 4540 of 6324 Results
Title
Year
  • Year
  • 2014
  • 2024
  • 2022
  • 2019
  • 2010
  • 2019
  • 2022
  • 2018
  • 2025
  • 2021
  • Summary Details
    OPEN
    Title: Comparison of voluntary and reflex cough effectiveness in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.09.010
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Single molecule array measures of LRRK2 kinase activity in serum link Parkinson’s disease severity to peripheral inflammation
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-024-00738-4
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson′s Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29124
    Citation Count: 7
  • Summary Details
    OPEN
    Title: The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohort
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-019-0077-5
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23442
    Citation Count: 167
  • Summary Details
    OPEN
    Title: Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jalz.2019.01.012
    Citation Count: 43
  • Summary Details
    OPEN
    Title: A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells11061018
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Somatic copy number gains of α-synuclein (SNCA) in Parkinson’s disease and multiple system atrophy brains
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awy157
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Genome-wide association study of REM sleep behavior disorder in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01078-w
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities
    Journal Name: Physiology News
    Publisher: The Physiological Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.36866/123.32
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.